Using cellular mechanisms to develop effective combinations of photodynamic therapy and targeted therapies

JNCCN Journal of the National Comprehensive Cancer Network

Volumn 10, Issue SUPP.2, 2012, Pages

  Hasan, Tayyaba ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOLEVULINIC ACID; ANDROGEN; BENZOPORPHYRIN DERIVATIVE; BEVACIZUMAB; CARBOPLATIN; CETUXIMAB; CISPLATIN; COPROPORPHYRINOGEN OXIDASE; EPIDERMAL GROWTH FACTOR RECEPTOR; FLUOROURACIL; METHOTREXATE; RETINOID; RETINOID X RECEPTOR; VASCULOTROPIN; VITAMIN D;

APOPTOSIS; CANCER GROWTH; CANCER RESISTANCE; CELL SURVIVAL; ENZYME ACTIVITY; HUMAN; IMMUNOTHERAPY; IN VITRO STUDY; IN VIVO STUDY; LOW DRUG DOSE; LUNG METASTASIS; MICROMETASTASIS; MOLECULARLY TARGETED THERAPY; MONOTHERAPY; NONHUMAN; OVARY CANCER; PANCREAS CANCER; PATIENT MONITORING; PHOTODYNAMIC THERAPY; PREMEDICATION; PROSTATE CANCER; PROTEIN EXPRESSION; SHORT SURVEY; SIGNAL TRANSDUCTION; SKIN CARCINOMA; SQUAMOUS CELL CARCINOMA; TREATMENT RESPONSE; TUMOR DIFFERENTIATION; TUMOR VOLUME;

EID: 84871238336     PISSN: 15401405     EISSN: 15401413     Source Type: Journal    
DOI: 10.6004/jnccn.2012.0168     Document Type: Short Survey

References (13)

1. del Carmen MG, Rizvi I, Chang Y, et al. Synergism of epidermal growth factor receptor-targeted immunotherapy with photodynamic treatment of ovarian cancer in vivo. J Natl Cancer Inst 2005;97:1516-1524. (Pubitemid 41631951)
2. Chang SK, Rizvi I, Solban N, et al. In vivo optical molecular imaging of vascular endothelial growth factor for monitoring cancer treatment. Clin Cancer Res 2008;14:4146-4153.
3. Abu-Yousif AO, Moor AC, Zheng X, et al. Epidermal growth factor receptor-targeted photosensitizer selectively inhibits EGFR signaling and induces targeted phototoxicity in ovarian cancer cells. Cancer Lett 2012;321:120-127.
4. Duska LR, Hamblin MR, Miller JL, Hasan T. Combination photoimmunotherapy and cisplatin: effects on human ovarian cancer ex vivo. J Natl Cancer Inst 1999;91:1557-1563. (Pubitemid 29457960)
5. Rizvi I, Celli JP, Evans CL, et al. Synergistic enhancement of carboplatin efficacy with photodynamic therapy in a three-dimensional model for micrometastatic ovarian cancer. Cancer Res 2010;70:9319-9328.
6. Cengel KA, Glatstein E, Hahn SM. Intraperitoneal photodynamic therapy. Cancer Treat Res 2007;134:493-514.
7. Zhong W, Celli JP, Rizvi I, et al. In vivo high-resolution fluorescence microendoscopy for ovarian cancer detection and treatment monitoring. Br J Cancer 2009;101:2015-2022.
8. Celli JP, Solban N, Liang A, et al. Verteporfin-based photodynamic therapy overcomes gemcitabine insensitivity in a panel of pancreatic cancer cell lines. Lasers Surg Med 2011;43:565-574.
9. Evans CL, Abu-Yousif AO, Park YJ, et al. Killing hypoxic cell populations in a 3D tumor model with EtNBS-PDT. PLoS One 2011;6:e23434.
10. Ortel B, Chen N, Brissette J, et al. Differentiation-specific increase in ALA-induced protoporphyrin IX accumulation in primary mouse keratinocytes. Br J Cancer 1998;77:1744-1751. (Pubitemid 28254607)
11. Ortel B, Sharlin D, O'Donnell D, et al. Differentiation enhances aminolevulinic acid-dependent photodynamic treatment of LNCaP prostate cancer cells. Br J Cancer 2002;87:1321-1327. (Pubitemid 36009140)
12. Anand S, Honari G, Hasan T, et al. Low-dose methotrexate enhances aminolevulinate-based photodynamic therapy in skin carcinoma cells in vitro and in vivo. Clin Cancer Res 2009;15:3333-3343.
13. Anand S, Wilson C, Hasan T, Maytin EV. Vitamin D3 enhances the apoptotic response of epithelial tumors to aminolevulinate-based photodynamic therapy. Cancer Res 2011;71:6040-6050.